Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Oxidation changes the structure of hair protein filaments, causing them to compact and rearrange.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Biliverdin IXβ and IXδ help Pseudomonas aeruginosa adapt to chronic infections.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

The method reliably profiles eicosanoids and shows epitestosterone reduces their levels, similar to common anti-inflammatory drugs.

Metabolite 7 is a strong inhibitor for Alzheimer's disease management.

Enzymes play crucial roles in metabolism, health, and disease management.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Steroid-binding globulins have important roles beyond just transporting steroids.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.